Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
0.9951
-0.0009 (-0.09%)
At close: Jul 11, 2025, 4:00 PM
1.040
+0.045 (4.51%)
After-hours: Jul 11, 2025, 7:53 PM EDT

Nexalin Technology Revenue

Nexalin Technology had revenue of $41.02K in the quarter ending March 31, 2025, a decrease of -47.87%. This brings the company's revenue in the last twelve months to $131.07K, down -17.50% year-over-year. In the year 2024, Nexalin Technology had annual revenue of $168.72K with 52.35% growth.

Revenue (ttm)
$131.07K
Revenue Growth
-17.50%
P/S Ratio
81.11
Revenue / Employee
$21,844
Employees
6
Market Cap
17.33M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 168.72K 57.97K 52.35%
Dec 31, 2023 110.75K -1.21M -91.62%
Dec 31, 2022 1.32M 1.18M 817.20%
Dec 31, 2021 144.07K -98.85K -40.69%
Dec 31, 2020 242.91K 35.53K 17.13%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings